ArticleJCEM case reports2026
Copeptin as a diagnostic tool in a patient with adipsia and hypernatremia.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Classic adipsic vasopressin deficiency features hypotonic polyuria and absent thirst despite hypernatremia. We report a 21-year-old patient with prior resected pilocytic astrocytoma who presented dehydration and hypernatremia of 158 mEq/L (158 mmol/L) (reference range, 135-145 mEq/L [SI: 135-145 mmol/L]). He denied thirst and had no polyuria or polydipsia. Plasma and urinary osmolalities were 317 mOsm/Kg (317 mmol/Kg) (reference range, 282-295 mOsm/Kg [282-295 mmol/Kg]) and 878 mOsm/Kg (878 mmol/Kg) (reference range, 200-1200 mOsm/Kg [200-1200 mmol/Kg]), respectively. After prescribed oral water intake, serum sodium normalized and urinary volume remained normal. To assess osmoregulation, plasma copeptin and thirst visual scale were assessed during 3% saline infusion. Despite increases in serum sodium, the patient reported no change in thirst, confirming adipsia. Copeptin value was 3.2 pmol/L at the end of the saline infusion (reference range, 3.7-43.3 pmol/L) and 4.1 pmol/L during hypovolemic hypernatremia, both low-normal values considering hypernatremia, suggesting impaired osmolality-driven vasopressin secretion. This case illustrates a partial defect in osmoregulatory vasopressin release with maintained renal response and highlights the diagnostic utility of osmotic-stimulated copeptin measurement for functional characterization of vasopressin dynamics in rare adipsic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.